drug · small molecule
CB-011
Phase 1updated 6mo agoby $CRBU Caribou Biosciences, Inc.🔗 ChEMBL
Phase 1community read0 votes
Small molecule drug with a maximum clinical stage of Approval, with an approval for diarrhea.
targets
DNA-directed RNA polymerase
all catalysts(0)
nothing on the calendar yet
Trials studying CB-011
News(4)
- Biopharma layoffs rise YOY in October but sharply trend down for 2026October marked the first time this year there was an increase in both the number of biotech and pharma companies trimming their workforces and the number of affected employees when compared to 2025…biospace · 7d ago
- Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climateDespite having an allogeneic cell therapy prospect that’s ready for late-stage testing in lymphoma, Caribou couldn’t secure funding to support the effort and will now pursue “strategic alternatives…biopharma_dive · 1mo ago
- Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes upCaribou Biosciences entered the scene in 2011 and went public in 2021. Over the course of its existence, the biotech has received funding and support from a handful of Big Pharma players, including…biospace · 1mo ago
- CAR-T biotech Caribou makes ‘heartbreaking’ call to shrink headcount, halt pipelineThe Bay Area biotech is discontinuing all clinical development activities and implementing a "substantial reduction in workforce."fiercebiotech · 1mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that